Tema ETF Trust
Tema Neuroscience and Mental Health ETF
$8.90M
Avg Monthly Net Assets
$10.79M
Total Assets
$9K
Total Liabilities
$10.78M
Net Assets
Tema Neuroscience and Mental Health ETF is an Exchange-Traded Fund in Tema ETF Trust
,
based in New York,
United States of America.
The fund has one share class
and monthly net assets of $8.90M.
On July 22nd, 2024 it reported 45 holdings, the largest
being Vertex Pharmaceuticals Inc (5.8%), Eli Lilly & Co (5.4%) and Regeneron Pharmaceuticals Inc (4.8%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| Tema Neuroscience and Mental Health ETF | C000244457 | XNAS | MNTL |
Holdings
From latest NPORT-P, filed July 22nd, 2024 for period ending May 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| Acadia Healthcare Co Inc | Long | Equity-common | US | $179K | 3K | 1.66 |
| ACADIA Pharmaceuticals Inc | Long | Equity-common | US | $160K | 11K | 1.48 |
| Alector Inc | Long | Equity-common | US | $71K | 14K | 0.65 |
| Alkermes PLC | Long | Equity-common | IE | $139K | 6K | 1.29 |
| Alnylam Pharmaceuticals Inc | Long | Equity-common | US | $261K | 2K | 2.42 |
| Argenx SE | Long | Equity-common | NL | $385K | 1K | 3.58 |
| Arvinas Inc | Long | Equity-common | US | $102K | 3K | 0.95 |
| Axsome Therapeutics Inc | Long | Equity-common | US | $145K | 2K | 1.35 |
| Biogen Inc | Long | Equity-common | US | $504K | 2K | 4.68 |
| Biohaven Ltd | Long | Equity-common | US | $105K | 3K | 0.98 |
| Catalyst Pharmaceuticals Inc | Long | Equity-common | US | $184K | 11K | 1.70 |
| Crinetics Pharmaceuticals Inc | Long | Equity-common | US | $346K | 8K | 3.21 |
| Day One Biopharmaceuticals Inc | Long | Equity-common | US | $266K | 20K | 2.46 |
| Denali Therapeutics Inc | Long | Equity-common | US | $402K | 22K | 3.73 |
| Dexcom Inc | Long | Equity-common | US | $361K | 3K | 3.35 |
| Eisai Co Ltd | Long | Equity-common | JP | $87K | 2K | 0.81 |
| Eli Lilly & Co | Long | Equity-common | US | $578K | 704 | 5.36 |
| First American Treasury Obligations Fund | Long | Short-term investment vehicle | US | $251K | 251K | 2.33 |
| Immunovant Inc | Long | Equity-common | US | $87K | 3K | 0.81 |
| Intellia Therapeutics Inc | Long | Equity-common | US | $236K | 11K | 2.19 |
| Intra-Cellular Therapies Inc | Long | Equity-common | US | $228K | 3K | 2.11 |
| Ionis Pharmaceuticals Inc | Long | Equity-common | US | $284K | 8K | 2.64 |
| Jazz Pharmaceuticals PLC | Long | Equity-common | US | $176K | 2K | 1.63 |
| Medtronic PLC | Long | Equity-common | IE | $286K | 4K | 2.66 |
| Neurocrine Biosciences Inc | Long | Equity-common | US | $481K | 4K | 4.46 |
| Nevro Corp | Long | Equity-common | US | $51K | 5K | 0.47 |
| Option Care Health Inc | Long | Equity-common | US | $183K | 6K | 1.70 |
| Orion Oyj | Long | Equity-common | FI | $59K | 1K | 0.54 |
| Penumbra Inc | Long | Equity-common | US | $298K | 2K | 2.77 |
| Prothena Corp PLC | Long | Equity-common | IE | $219K | 11K | 2.03 |
| PTC Therapeutics Inc | Long | Equity-common | US | $114K | 3K | 1.05 |
| Quanterix Corp | Long | Equity-common | US | $100K | 6K | 0.93 |
| Regeneron Pharmaceuticals Inc | Long | Equity-common | US | $518K | 528 | 4.80 |
| Sarepta Therapeutics Inc | Long | Equity-common | US | $222K | 2K | 2.06 |
| Scholar Rock Holding Corp | Long | Equity-common | US | $67K | 7K | 0.62 |
| Siemens Healthineers AG | Long | Equity-common | DE | $224K | 4K | 2.08 |
| Silk Road Medical Inc | Long | Equity-common | US | $144K | 7K | 1.33 |
| Stryker Corp | Long | Equity-common | US | $420K | 1K | 3.90 |
| Sysmex Corp | Long | Equity-common | JP | $104K | 6K | 0.97 |
| Talkspace Inc | Long | Equity-common | US | $92K | 35K | 0.85 |
| Teva Pharmaceutical Industries Ltd | Long | Equity-common | IL | $370K | 22K | 3.43 |
| UCB SA | Long | Equity-common | BE | $344K | 2K | 3.19 |
| Vertex Pharmaceuticals Inc | Long | Equity-common | US | $628K | 1K | 5.83 |
| Voyager Therapeutics Inc | Long | Equity-common | US | $126K | 15K | 1.17 |
| Xenon Pharmaceuticals Inc | Long | Equity-common | CA | $189K | 5K | 1.76 |
Address
Tema ETF Trust
Brookfield Place
200 Vesey Street, Suite 24106
New York
New York
10281
United States of America
Websites
Directors
John Jacobs
Richard Keary
Robert Sherry
Matthew Keeling
Transfer Agents
U.S. Bancorp Fund Services, LLC
Pricing Services
Intercontinental Exchange Inc.
Bloomberg
Custodians
US Bank National Association
Skandinaviska Enskilda Banken AB (publ) (SEB)
BNP Paribas, London Branch
RBC Investor Services Trust
The Bank of New York Mellon
Shareholder Servicing Agents
N/A
Admins
U.S. Bancorp Fund Services LLC
Brokers
NORTHERN TRUST SECURITIES, INC.